Início › Câncer Colorretal › Utah › West Valley City
Ensaios clínicos de Câncer Colorretal em West Valley City, UT
17 estudos para Câncer Colorretal estão buscando participantes em locais em West Valley City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
RecrutandoFase 2
- START Mountain Region, West Valley City
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecrutandoFase 1
- ALX Center 4, West Valley City
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A Study of MGC026 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, LLC., West Valley City
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecrutandoFase 1
- START Mountain Region, LLC, West Valley City
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RecrutandoFase 1
- START Mountain Region, LLC, West Valley City
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecrutandoFase 1/2
- START Mountain Region, West Valley City
A Study of MGC028 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecrutandoFase 1/2
- START Mountain Region, West Valley City
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- START Mountain Region, West Valley City
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RecrutandoFase 1/2
- START, Mountain Region, West Valley City
Ensaios de Câncer Colorretal em outras cidades
- Houston, TX102 estudos
- New York City, NY78 estudos
- Nashville, TN69 estudos
- Boston, MA63 estudos
- Los Angeles, CA59 estudos
- Arlington, VA52 estudos
- St. Louis, MO50 estudos
- San Antonio, TX46 estudos
- Philadelphia, PA44 estudos
- Grand Rapids, MI40 estudos
- Baldwin Park, CA37 estudos
- Chicago, IL34 estudos
Outros estudos em West Valley City
- Câncer de Pulmão de Não Pequenas Células25 estudos
- Câncer de Mama13 estudos
- Câncer de Mama Triplo-Negativo13 estudos
- Câncer Metastático13 estudos
- Câncer de Pâncreas12 estudos
- Câncer (todos os tipos)11 estudos
- Câncer de Ovário11 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço11 estudos
- Câncer Endometrial10 estudos
- Câncer de Estômago8 estudos
- Carcinoma de Células Escamosas Esofágico7 estudos
- Câncer de Pulmão de Células Pequenas7 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.